Tablet
Latest Merck & Co., Inc. Patents:
- Assays for resistance to echinocandin-class drugs
- ASSAYS FOR RESISTANCE TO ECHINOCANDIN-CLASS DRUGS
- Assays for resistance to echinocandin-class drugs
- INTEGRIN TARGETING AGENTS AND IN-VIVO AND IN-VITRO IMAGING METHODS USING THE SAME
- Integrin targeting agents and in-vivo and in-vitro imaging methods using the same
Description
FIG. 1 is a perspective view of a tablet showing our new design, on an enlarged scale;
FIG. 2 is a rear elevation view thereof;
FIG. 3 is a top plan view thereof, the bottom view beng a mirror image thereof;
FIG. 4 is a right side elevation view, the left side elevation view being a mirror image thereof; and,
FIG. 5 is a front elevational view thereof.
Referenced Cited
U.S. Patent Documents
Other references
47083 | March 1915 | Swaab, Jr. |
D187372 | March 1960 | Dailey |
D213873 | April 1969 | Bryan |
D269128 | May 24, 1983 | Hiscock |
D285363 | August 26, 1986 | Tovey |
D286085 | October 7, 1986 | Tovey |
D309506 | July 24, 1990 | Shurkus |
D314442 | February 5, 1991 | Shoh et al. |
- Physician's Desk Reference, 1990, p. 419 (Triavil). Physician's Desk Reference, 1990, p. 430 )Dexedrine). Physician's Desk Reference, 1990, p. 410 (Tofranil). Physician's Desk Reference, 1990, p. 426 (Atarax).
Patent History
Patent number: D375157
Type: Grant
Filed: Dec 22, 1992
Date of Patent: Oct 29, 1996
Assignee: Merck & Co., Inc. (Rahway, NJ)
Inventors: Kenneth A. Kramer (Green Lane, PA), Ashok V. Katdare (Norristown, PA)
Primary Examiner: M. H. Tung
Attorneys: Joanne M. Giesser, Robert J. North, Melvin Winokur
Application Number: 0/2,841
Type: Grant
Filed: Dec 22, 1992
Date of Patent: Oct 29, 1996
Assignee: Merck & Co., Inc. (Rahway, NJ)
Inventors: Kenneth A. Kramer (Green Lane, PA), Ashok V. Katdare (Norristown, PA)
Primary Examiner: M. H. Tung
Attorneys: Joanne M. Giesser, Robert J. North, Melvin Winokur
Application Number: 0/2,841
Classifications
Current U.S. Class:
Tablet Or Caplet (1) (D24/101)